Medpace
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medpace and other ETFs, options, and stocks.About MEDP
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.
CEOAugust James Troendle
CEOAugust James Troendle
Employees5,900
Employees5,900
HeadquartersCincinnati, Ohio
HeadquartersCincinnati, Ohio
Founded1992
Founded1992
Employees5,900
Employees5,900
MEDP Key Statistics
Market cap15.12B
Market cap15.12B
Price-Earnings ratio40.45
Price-Earnings ratio40.45
Dividend yield—
Dividend yield—
Average volume304.06K
Average volume304.06K
High today$542.43
High today$542.43
Low today$521.84
Low today$521.84
Open price$521.84
Open price$521.84
Volume279.33K
Volume279.33K
52 Week high$547.15
52 Week high$547.15
52 Week low$250.05
52 Week low$250.05
MEDP News
TipRanks 8h
Medpace downgraded to Underweight from Equal Weight at BarclaysBarclays downgraded Medpace (MEDP) to Underweight from Equal Weight with a price target of $425, down from $450. The downgrade is mostly on valuation, as Barcla...
Analyst ratings
57%
of 14 ratingsBuy
7.1%
Hold
57.1%
Sell
35.7%
People also own
Based on the portfolios of people who own MEDP. This list is generated using Robinhood data, and it’s not a recommendation.